Article Type
Changed
Thu, 06/20/2019 - 13:10
Display Headline
BEST PRACTICES IN: The Use of XERESE® (acyclovir and hydrocortisone) Cream 5%/1% to Help Reduce the Likelihood of Progression to Ulcerative Cold Sores

Medical Education Library

A supplement to Skin & Allergy News. This supplement was sponsored by Medicis, a division of Valeant Pharmaceuticals.

 

Topics

 

  • Herpes Simplex Virus-1: Prevalence and Diagnosis
  • HSL Treatment
  • XERESE® (acyclovir and hydrocortisone) Cream 5%/1%
  • Summary and Conclusions
  • INDICATION
  • IMPORTANT SAFETY INFORMATION

Faculty/Faculty Disclosure

Joseph Fowler, MD
University of Louisville
Louisville, Kentucky

Dr. Fowler reported that he is a member of the speakers’ bureau for Valeant Pharmaceuticals and received compensation from Valeant for his assistance in developing the content of this article.

LINKS: Click Here for PDF.

Copyright © by Frontline Medical Communications Inc.

Author and Disclosure Information

 

 

Publications
Sections
Author and Disclosure Information

 

 

Author and Disclosure Information

 

 

Medical Education Library

A supplement to Skin & Allergy News. This supplement was sponsored by Medicis, a division of Valeant Pharmaceuticals.

 

Topics

 

  • Herpes Simplex Virus-1: Prevalence and Diagnosis
  • HSL Treatment
  • XERESE® (acyclovir and hydrocortisone) Cream 5%/1%
  • Summary and Conclusions
  • INDICATION
  • IMPORTANT SAFETY INFORMATION

Faculty/Faculty Disclosure

Joseph Fowler, MD
University of Louisville
Louisville, Kentucky

Dr. Fowler reported that he is a member of the speakers’ bureau for Valeant Pharmaceuticals and received compensation from Valeant for his assistance in developing the content of this article.

LINKS: Click Here for PDF.

Copyright © by Frontline Medical Communications Inc.

Medical Education Library

A supplement to Skin & Allergy News. This supplement was sponsored by Medicis, a division of Valeant Pharmaceuticals.

 

Topics

 

  • Herpes Simplex Virus-1: Prevalence and Diagnosis
  • HSL Treatment
  • XERESE® (acyclovir and hydrocortisone) Cream 5%/1%
  • Summary and Conclusions
  • INDICATION
  • IMPORTANT SAFETY INFORMATION

Faculty/Faculty Disclosure

Joseph Fowler, MD
University of Louisville
Louisville, Kentucky

Dr. Fowler reported that he is a member of the speakers’ bureau for Valeant Pharmaceuticals and received compensation from Valeant for his assistance in developing the content of this article.

LINKS: Click Here for PDF.

Copyright © by Frontline Medical Communications Inc.

Publications
Publications
Article Type
Display Headline
BEST PRACTICES IN: The Use of XERESE® (acyclovir and hydrocortisone) Cream 5%/1% to Help Reduce the Likelihood of Progression to Ulcerative Cold Sores
Display Headline
BEST PRACTICES IN: The Use of XERESE® (acyclovir and hydrocortisone) Cream 5%/1% to Help Reduce the Likelihood of Progression to Ulcerative Cold Sores
Sections
Disallow All Ads
Alternative CME
Use ProPublica